A new report has claimed targeting inflammation could have benefits for individuals who have been diagnosed with Alzheimer's disease.
Scientists from universities in Germany and Switzerland found antibodies that are designed to block two proteins involved in inflammation are able to reduce features of Alzheimer's in mice.
Head of research at Alzheimer's Research UK Dr Simon Ridley stated this latest study adds to increasing evidence of the role inflammation plays in the development of the disease.
"It is an exciting area for researchers working to defeat this devastating disease. This promising research adds further support for the role of the immune system in Alzheimer's," he said.
But Dr Ridley stressed the need for caution, noting conclusions from studies on mice can not necessarily be drawn for humans.
Research carried out at the University of California in Los Angeles recently showed leading an active lifestyle could enable older adults to slow the onset of Alzheimer's disease.
Find out about dementia care and support services at Barchester care homes.